John C. Vederas

24.0k total citations · 4 hit papers
361 papers, 16.9k citations indexed

About

John C. Vederas is a scholar working on Molecular Biology, Pharmacology and Food Science. According to data from OpenAlex, John C. Vederas has authored 361 papers receiving a total of 16.9k indexed citations (citations by other indexed papers that have themselves been cited), including 228 papers in Molecular Biology, 99 papers in Pharmacology and 82 papers in Food Science. Recurrent topics in John C. Vederas's work include Microbial Natural Products and Biosynthesis (84 papers), Probiotics and Fermented Foods (80 papers) and Chemical Synthesis and Analysis (34 papers). John C. Vederas is often cited by papers focused on Microbial Natural Products and Biosynthesis (84 papers), Probiotics and Fermented Foods (80 papers) and Chemical Synthesis and Analysis (34 papers). John C. Vederas collaborates with scholars based in Canada, United States and France. John C. Vederas's co-authors include Stephen A. Cochrane, Marco J. van Belkum, Michael E. Stiles, Christopher T. Lohans, Clarissa S. Sit, C. Richard Hutchinson, Karine Auclair, Lee D. Arnold, Kenneth L. Roy and Jonathan Kennedy and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

John C. Vederas

357 papers receiving 16.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug Discovery and Natural Products: End of an Era or an Endless Frontier?

2009 1.6k citations John C. Vederas et al. profile →
Modulation of Polyketide Synthase Activity by Accessory Proteins During Lovastatin Biosynthesis

1999 528 citations John C. Vederas et al. profile →
Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile

2010 406 citations Mary C. Rea, Clarissa S. Sit et al. Proceedings of the National Academy of Sciences profile →
Lipopeptides from Bacillus and Paenibacillus spp.: A Gold Mine of Antibiotic Candidates

2014 381 citations Stephen A. Cochrane, John C. Vederas profile →

Peers

John C. Vederas

PHARM

BIOTE

Charles O. Rock United States

Ettore Novellino Italy

John E. Cronan United States

Wilfred A. van der Donk United States

Christian R.H. Raetz United States

Roderich D. Süßmuth Germany

Michael R. Boyd United States

Mohamed A. Marahiel Germany

N.C.J. Strynadka Canada

Gordon M. Cragg United States

Charles O. Rock United States

John C. Vederas

13.6k ×1.4

2.6k ×0.6

PHARM

2.9k ×0.8

1.1k ×0.3

895 ×0.5

BIOTE

Citations per year, relative to John C. Vederas John C. Vederas (= 1×) peers Charles O. Rock

Countries citing papers authored by John C. Vederas

Since Specialization

Citations

This map shows the geographic impact of John C. Vederas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Vederas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Vederas more than expected).

Fields of papers citing papers by John C. Vederas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Vederas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Vederas. The network helps show where John C. Vederas may publish in the future.

Co-authorship network of co-authors of John C. Vederas

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Vederas. A scholar is included among the top collaborators of John C. Vederas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Vederas. John C. Vederas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lamer, Tess, et al.. (2025). Structure and inhibition of diaminopimelic acid epimerase by slow‐binding α‐methyl amino acids. Protein Science. 34(5). e70139–e70139.

Lamer, Tess, Tamara Aleksandrzak‐Piekarczyk, Ryan T. McKay, et al.. (2025). Solution Structure of the Broad-Spectrum Bacteriocin Garvicin Q. International Journal of Molecular Sciences. 26(16). 7846–7846.

Grin, Peter M., Kaushal Baid, Hugo César Ramos de Jesus, et al.. (2024). SARS-CoV-2 3CLpro (main protease) regulates caspase activation of gasdermin-D/E pores leading to secretion and extracellular activity of 3CLpro. Cell Reports. 43(12). 115080–115080. 6 indexed citations

Fischer, Conrad, Marco J. van Belkum, Tess Lamer, et al.. (2024). Assessment of optimized FRET substrates as universal corona- and picornavirus main protease substrates for screening assays. RSC Advances. 14(48). 35438–35446.

Fischer, Conrad, Mahmoud Gheblawi, Wang Wang, et al.. (2021). Metabolically stable apelin-analogues, incorporating cyclohexylalanine and homoarginine, as potent apelin receptor activators. RSC Medicinal Chemistry. 12(8). 1402–1413. 11 indexed citations

Arutyunova, Elena, Muhammad Bashir Khan, Conrad Fischer, et al.. (2021). N-Terminal Finger Stabilizes the S1 Pocket for the Reversible Feline Drug GC376 in the SARS-CoV-2 Mpro Dimer. Journal of Molecular Biology. 433(13). 167003–167003. 33 indexed citations

Vuong, Wayne, Muhammad Bashir Khan, Conrad Fischer, et al.. (2020). Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication. Nature Communications. 11(1). 4282–4282. 340 indexed citations

Fischer, Conrad, et al.. (2019). Catalytic mechanism and properties of pyridoxal 5′-phosphate independent racemases: how enzymes alter mismatched acidity and basicity. Natural Product Reports. 36(12). 1687–1705. 14 indexed citations

Lin, Jiaxin, Abul Kalam Azad, Maikel Farhan, et al.. (2019). Apelin directs endothelial cell differentiation and vascular repair following immune-mediated injury. Journal of Clinical Investigation. 130(1). 94–107. 52 indexed citations

10.

Fischer, Conrad, et al.. (2018). Isolation, expression and biochemical characterization of recombinant hyoscyamine-6β-hydroxylase from Brugmansia sanguinea – tuning the scopolamine production. MedChemComm. 9(5). 888–892. 10 indexed citations

11.

Fischer, Conrad, et al.. (2018). PLP-independent racemization: mechanistic and mutational studies ofO-ureidoserine racemase (DcsC). Organic & Biomolecular Chemistry. 16(7). 1126–1133. 10 indexed citations

12.

Caldo, Kristian Mark P., et al.. (2017). Diacylglycerol Acyltransferase 1 Is Regulated by Its N-Terminal Domain in Response to Allosteric Effectors. PLANT PHYSIOLOGY. 175(2). 667–680. 43 indexed citations

13.

Cochrane, Stephen A., et al.. (2016). Antimicrobial lipopeptide tridecaptin A ₁ selectively binds to Gram-negative lipid II. Proceedings of the National Academy of Sciences. 113(41). 11561–11566. 110 indexed citations

14.

Lin, Xiaoxi B., Christopher T. Lohans, Rebbeca M. Duar, et al.. (2015). Genetic Determinants of Reutericyclin Biosynthesis in Lactobacillus reuteri. Applied and Environmental Microbiology. 81(6). 2032–2041. 53 indexed citations

15.

Rea, Mary C., Clarissa S. Sit, Evelyn M. Clayton, et al.. (2010). Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proceedings of the National Academy of Sciences. 107(20). 9352–9357. 406 indexed citations breakdown →

16.

Gao, Zhizeng, et al.. (2010). Insights into Radicicol Biosynthesis via Heterologous Synthesis of Intermediates and Analogs. Journal of Biological Chemistry. 285(53). 41412–41421. 85 indexed citations

17.

Huitema, Carly, Jianmin Zhang, Yin Jiang, et al.. (2008). Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase: Evaluation of mode of action. Bioorganic & Medicinal Chemistry. 16(10). 5761–5777. 15 indexed citations

18.

Sprules, Tara, Karen E. Kawulka, & John C. Vederas. (2004). NMR Solution Structure of ImB2, a Protein Conferring Immunity to Antimicrobial Activity of the Type IIa Bacteriocin, Carnobacteriocin B2^,. Biochemistry. 43(37). 11740–11749. 32 indexed citations

19.

Kawulka, Karen E., Tara Sprules, Ryan T. McKay, et al.. (2003). Structure of Subtilosin A, an Antimicrobial Peptide from Bacillus s ubtilis with Unusual Posttranslational Modifications Linking Cysteine Sulfurs to α-Carbons of Phenylalanine and Threonine. Journal of the American Chemical Society. 125(16). 4726–4727. 101 indexed citations

20.

Quadri, Luis E. N., Michiel Kleerebezem, Oscar P. Kuipers, et al.. (1997). Characterization of a Locus from Carnobacterium piscicola LV17B Involved in Bacteriocin Production and Immunity. Default journal. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact